AAN 2021 | Rapid progress in the migraine space

Meaningful growth in our understanding of migraine pathophysiology has expedited clinical progress, with several novel mechanism-based treatments emerging. Dawn C. Buse, PhD, Albert Einstein College of Medicine, New York, NY, talks on the latest developments in migraine care and how new approaches may address unmet needs. Progress has been made in all areas of migraine research, including pharmacological acute and preventative treatments. Prof. Buse also notes the growth in our understanding of migraine triggers, disease burden, and the importance of social and lifestyle factors. This interview took place during the American Academy of Neurology (AAN) 2021 Annual Meeting.